These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2075239)

  • 1. Overview of eicosanoid metabolism and relationship to platelet-activating factor.
    Dusting GJ; Stewart AG
    Reprod Fertil Dev; 1990; 2(5):417-21. PubMed ID: 2075239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolism and action mechanisms of eicosanoids and platelet-activating factor in the kidney].
    Watanabe T
    Nihon Rinsho; 1992 Dec; 50(12):2937-48. PubMed ID: 1337118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.
    Quinn JV; Slotman GJ
    Crit Care Med; 1999 Nov; 27(11):2485-94. PubMed ID: 10579269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic options directed against platelet activating factor, eicosanoids and bradykinin in sepsis.
    Fink MP
    J Antimicrob Chemother; 1998 Jan; 41 Suppl A():81-94. PubMed ID: 9511090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology.
    Harizi H; Corcuff JB; Gualde N
    Trends Mol Med; 2008 Oct; 14(10):461-9. PubMed ID: 18774339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological inhibition of eicosanoids and platelet-activating factor signaling impairs zymosan-induced release of IL-23 by dendritic cells.
    Rodríguez M; Márquez S; Montero O; Alonso S; Frade JG; Crespo MS; Fernández N
    Biochem Pharmacol; 2016 Feb; 102():78-96. PubMed ID: 26673542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ocular effects of eicosanoids and other autacoids: historic background and the need for a broader perspective.
    Stjernschantz J; Bito LZ
    Prog Clin Biol Res; 1989; 312():1-13. PubMed ID: 2571999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid inflammatory mediators: leukotrienes, prostaglandins, platelet-activating factor.
    Christie PE; Henderson WR
    Clin Allergy Immunol; 2002; 16():233-54. PubMed ID: 11577541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular biology of eicosanoids and atherogenesis.
    Praticò D; Dogné JM
    Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1079-89. PubMed ID: 19764861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eicosanoids and platelet activating factor as possible mediators of injury in experimental nephropathies.
    Remuzzi G
    Adv Exp Med Biol; 1989; 259():221-47. PubMed ID: 2696353
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune-regulation and -functions of eicosanoid lipid mediators.
    Esser-von Bieren J
    Biol Chem; 2017 Oct; 398(11):1177-1191. PubMed ID: 28622139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of eicosanoids in regulation of macrophage phagocytic functions by platelet-activating factor during endotoxic shock.
    Zaitseva L; Vaisburd M; Shaposhnikova G; Mysyakin E
    Bull Exp Biol Med; 2000 Sep; 130(9):879-81. PubMed ID: 11177271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopolysaccharide-induced leukocyte lipid body formation in vivo: innate immunity elicited intracellular Loci involved in eicosanoid metabolism.
    Pacheco P; Bozza FA; Gomes RN; Bozza M; Weller PF; Castro-Faria-Neto HC; Bozza PT
    J Immunol; 2002 Dec; 169(11):6498-506. PubMed ID: 12444160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of inflammatory diseases by selective eicosanoid inhibition: a double-edged sword?
    Yedgar S; Krimsky M; Cohen Y; Flower RJ
    Trends Pharmacol Sci; 2007 Sep; 28(9):459-64. PubMed ID: 17692394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future potential of eicosanoids and their inhibitors in paediatric practice.
    Shimizu T
    Drugs; 1998 Aug; 56(2):169-76. PubMed ID: 9711442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GM-CSF- and M-CSF-primed macrophages present similar resolving but distinct inflammatory lipid mediator signatures.
    Lukic A; Larssen P; Fauland A; Samuelsson B; Wheelock CE; Gabrielsson S; Radmark O
    FASEB J; 2017 Oct; 31(10):4370-4381. PubMed ID: 28637652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What are the effects of dietary fatty acid modification on platelet eicosanoid metabolism, platelet-activating factor, and platelet function? How might these metabolic alterations influence thrombosis?
    Prescott SM
    Am J Clin Nutr; 1992 Oct; 56(4 Suppl):801S-802S. PubMed ID: 1414987
    [No Abstract]   [Full Text] [Related]  

  • 18. Endothelin-1 stimulates eicosanoid production in cultured human nasal mucosa.
    Wu T; Mullol J; Rieves RD; Logun C; Hausfield J; Kaliner MA; Shelhamer JH
    Am J Respir Cell Mol Biol; 1992 Feb; 6(2):168-74. PubMed ID: 1311593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eicosanoids, inflammation, and anti-inflammatory drugs.
    Robinson DR
    Clin Exp Rheumatol; 1989; 7 Suppl 3():S155-61. PubMed ID: 2691152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations into the polydeterminant nature of sepsis.
    Goldfarb R
    Crit Care Med; 1999 Nov; 27(11):2587-8. PubMed ID: 10579296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.